Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Cocrystal Pharma Inc (NASDAQ: COCP) violated securities laws in connection with certain financial statements.
The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Cocrystal Pharma Inc (NASDAQ: COCP) concerning whether a series of statements by Cocrystal Pharma Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On September 7, 2018, the SEC filed a lawsuit against former officers of BioZone as well as other individuals and corporations, claiming violations of the federal securities laws. According to the SEC, allegedly the defendants were participants in “highly profitable ‘pump-and-dump’ schemes . . . from 2013 through 2018” in the stock of three public companies, including BioZone, that, “while enriching Defendants by millions of dollars, left retail investors holding virtually worthless shares.”
Following this news, NASDAQ: COCP fell over 14% on September 7, 2018.
Based in Tucker, Georgia, and founded in 2007 Cocrystal Pharma Inc engages in discovering and developing various novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses.
If you purchased shares of Cocrystal Pharma Inc (NASDAQ: COCP) on or before September 7, 2018, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.
Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.
Thieler Law Corp
2534 State Street - Suite 406,
San Diego, CA 92101
by
email: mail@thielerlaw.com
or
telephone at +1 (619) 377 - 4324
or
visit our website http://www.thielerlaw.com/
or
Facsimile: +1 (619) 785 – 3185
